Bioinformatics Analysis of the Prognostic Significance of VPS16 in Hepatocellular Carcinoma and Its Role in Drug Screening

Table 1

The clinical characteristics and protein expression of VPS16 in LIHC and normal tissues.

Number	Gender	Age (y)	Intensity	Quantity	SI	Staining
Cancer 1	F	73	3	4	12	High
Cancer 2	M	67	2	4	12	High
Cancer 3	M	59	2	4	8	High
Cancer 4	F	73	2	4	8	High
Cancer 5	F	58	1	1	1	Low
Cancer 6	F	53	3	4	12	High
Cancer 7	M	76	2	4	8	High
Cancer 8	M	67	3	4	12	High
Cancer 9	M	70	2	4	8	High
Cancer 10	M	72	2	4	8	High
Cancer 11	F	52	2	4	8	High
Cancer 12	M	65	2	3	6	High
Normal 1	F	54	2	1	2	Low
Normal 2	F	63	2	1	2	Low
Normal 3	M	55	2	1	2	Low

The data was downloaded from the HPA database (https://www.proteinatlas.org/). VPS16 expression intensity (0, 1+, 2+, and 3+) and positive cell percentage were evaluated, which were 0 (0%), 1 (1~25%), 2 (25~50%), 3 (50~75%), and 4 (75~100%), respectively. The staining index (SI) was calculated as follows: , was considered the low expression, and was considered the high expression.